﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/siegfried-names-eduardo-montanha-as-coo-to-drive-integrated-global-operations-20969</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/galmed-unveils-heart-targeted-aramchol-in-cardiac-fibrosis-push-20977</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/grunenthal-joins-munich-genetic-medicine-cluster-to-advance-rna-therapies-20976</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/oxford-launches-worlds-first-human-trial-of-bundibugyo-ebola-vaccine-20975</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/oh-boey-allergan-aesthetics-wins-european-approval-for-fast-acting-short-duration-wrinkle-treatment-20974</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/gsk-halts-camlipixant-development-after-mixed-phase-iii-results-in-chronic-cough-trials-20973</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/gsk-completes-106-billion-nuvalent-acquisition-expanding-push-into-lung-cancer-treatments-20972</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/grifols-advances-immunoglobulin-pipeline-with-two-new-phase-3-trials-20971</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/takedas-zasocitinib-delivers-broad-skin-clearance-in-phase-3-psoriasis-trials-20970</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/cordex-expands-global-access-strategy-for-zemcelpro-20978</loc><lastmod>2026-07-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>